Page 150 - Merck Sharp News Today

GSK withdraws HIBERIX in Vietnam due to low demand 16:41 | 15/12/2020 HIBERIX produced by GlaxoSmithKline A representative of GSK Vietnam told VIR that this is the vaccine for prevention of diseases caused by Haemophilus Influenzae type b bacteria for children, which have been already part of the current 5-in-1 vaccine provided to eligible children in the Expanded Program on Immunization (EPI) of the government for many years and there were other alternative vac...

Press release content from Business Wire. The AP news staff was not involved in its creation. Cervical Cancer Market Insight, Epidemiology and Market Forecast, 2030 - ResearchAndMarkets.com December 11, 2020 GMT DUBLIN--(BUSINESS WIRE)--Dec 11, 2020-- This ‘Cervical Cancer -Market Insights, Epidemiology, and Market Forecast-2030’ report delivers an in-depth understanding of the disease, historical, and forecasted epidemiology as well as the market trends of Cervical Cancer in the United Sta...

The Unjani clinic in KwaMashu is an example of this cost-effective and expanding model (Unjani Clinics) Merck Pharmaceuticals subsidiary MSD announces grant that will see the Unjani Clinics group hire more staff in their For Mothers Initiative. A global company has stepped in to support the local black women-owned Unjani Clinics with a R11.7 million investment. The Merck pharmaceuticals subsidiary Merck Sharp & Dohme (MSD) has decided to invest in the clinics where the demand for treatment is t...

Popular pharma products withdrawn by multinationals 10:00 | 10/12/2020 Popular pharma products withdrawn by multinationals, illustration photo According to the Drug Administration of Vietnam (DAV) under the Ministry of Health, as many as 20 pharmaceuticals of multinational corporations (MNCs) have requested and been granted revocation of marketing authorisation from registration units. Many pharma companies often request a withdrawal in order to rename or repacka...